We strive to break new ground in comprehensive care for patients living with the hepatitis C virus.
The hepatitis C virus (HCV) was once a hard to treat, chronic disease, but the availability of new treatments such as direct-acting antivirals (DAAs), which can virologically combat the disease in specific genotypes, are impacting the way we care for chronic HCV patients.
Exploring the “Why”: The Curious Path to Track the Hepatitis C Virus
Together with the HCV community, we are working to helping end HCV through awareness, screening, diagnosis and linkage to care programs.